JPRN-jRCT2031210474已完成2 期
Investigation of the safety and efficacy of semaglutide s.c. in combination with NNC0480-0389 in participants with type 2 diabetes - a dose finding study(NN9389-4606)
Oyatani Akihito0 个研究点目标入组 495 人开始时间: 2021年12月10日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 495
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Participants treated with diet and exercise as monotherapy or in combination with stable daily dose of any metformin formulations
排除标准
- •Severe heart failure, History of chronic pancreatitis, other
研究者
相似试验
进行中（未招募）
1 期
A research study looking at how well a combination of the medicines semaglutide and NNC0480-0389 works in people with type 2 diabetesDiabetes Mellitus, Type 2MedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2020-004863-14-GRovo Nordisk A/S500
进行中（未招募）
1 期
A research study looking at how well a combination of the medicines semaglutide and NNC0480-0389 works in people with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2020-004863-14-HUovo Nordisk A/S495
进行中（未招募）
1 期
A research study looking at how well a combination of the medicines semaglutide and NNC0480-0389 works in people with type 2 diabetesMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2020-004863-14-BGovo Nordisk A/S495
进行中（未招募）
1 期
A research study on how semaglutide works in people with fatty liver disease and liver damageEUCTR2018-004484-31-DEovo Nordisk A/S69
进行中（未招募）
1 期
A research study on how semaglutide works in people with fatty liver disease and liver damageNon-alcoholic steatohepatitis Compensated liver cirrhosisMedDRA version: 20.1 Level: PT Classification code 10053219 Term: Non-alcoholic steatohepatitis System Organ Class: 10019805 - Hepatobiliary disordersMedDRA version: 20.0 Level: LLT Classification code 10024667 Term: Liver cirrhosis System Organ Class: 10019805 - Hepatobiliary disordersEUCTR2018-004484-31-ESovo Nordisk A/S69